vs

Side-by-side financial comparison of CABOT CORP (CBT) and Shift4 Payments, Inc. (FOUR). Click either name above to swap in a different company.

Shift4 Payments, Inc. is the larger business by last-quarter revenue ($1.2B vs $849.0M, roughly 1.4× CABOT CORP). CABOT CORP runs the higher net margin — 8.6% vs 3.4%, a 5.2% gap on every dollar of revenue. On growth, Shift4 Payments, Inc. posted the faster year-over-year revenue change (34.0% vs -11.1%). Shift4 Payments, Inc. produced more free cash flow last quarter ($222.5M vs $57.0M). Over the past eight quarters, Shift4 Payments, Inc.'s revenue compounded faster (29.6% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Shift4 Payments, Inc. is an American payment processing company based in Allentown, Pennsylvania. The company, founded in 1999 by the then 16-year-old Jared Isaacman, processes payments for over 200,000 businesses in the retail, hospitality, leisure, and restaurant industries. Shift4 specializes in commerce technology such as mobile payment software and hardware. The company was publicly listed on the New York Stock Exchange in 2020.

CBT vs FOUR — Head-to-Head

Bigger by revenue
FOUR
FOUR
1.4× larger
FOUR
$1.2B
$849.0M
CBT
Growing faster (revenue YoY)
FOUR
FOUR
+45.1% gap
FOUR
34.0%
-11.1%
CBT
Higher net margin
CBT
CBT
5.2% more per $
CBT
8.6%
3.4%
FOUR
More free cash flow
FOUR
FOUR
$165.5M more FCF
FOUR
$222.5M
$57.0M
CBT
Faster 2-yr revenue CAGR
FOUR
FOUR
Annualised
FOUR
29.6%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBT
CBT
FOUR
FOUR
Revenue
$849.0M
$1.2B
Net Profit
$73.0M
$40.2M
Gross Margin
24.9%
Operating Margin
15.2%
10.8%
Net Margin
8.6%
3.4%
Revenue YoY
-11.1%
34.0%
Net Profit YoY
-21.5%
-65.3%
EPS (diluted)
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
FOUR
FOUR
Q4 25
$849.0M
$1.2B
Q3 25
$899.0M
$1.2B
Q2 25
$923.0M
$966.2M
Q1 25
$936.0M
$848.3M
Q4 24
$955.0M
$887.0M
Q3 24
$1.0B
$909.2M
Q2 24
$1.0B
$827.0M
Q1 24
$1.0B
$707.4M
Net Profit
CBT
CBT
FOUR
FOUR
Q4 25
$73.0M
$40.2M
Q3 25
$43.0M
$28.1M
Q2 25
$101.0M
$34.0M
Q1 25
$94.0M
$16.7M
Q4 24
$93.0M
$116.0M
Q3 24
$137.0M
$53.8M
Q2 24
$109.0M
$39.2M
Q1 24
$84.0M
$20.6M
Gross Margin
CBT
CBT
FOUR
FOUR
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Q1 24
24.1%
Operating Margin
CBT
CBT
FOUR
FOUR
Q4 25
15.2%
10.8%
Q3 25
15.2%
9.7%
Q2 25
18.1%
8.6%
Q1 25
17.3%
3.0%
Q4 24
16.2%
9.7%
Q3 24
15.0%
8.8%
Q2 24
16.9%
7.2%
Q1 24
15.3%
3.0%
Net Margin
CBT
CBT
FOUR
FOUR
Q4 25
8.6%
3.4%
Q3 25
4.8%
2.4%
Q2 25
10.9%
3.5%
Q1 25
10.0%
2.0%
Q4 24
9.7%
13.1%
Q3 24
13.7%
5.9%
Q2 24
10.7%
4.7%
Q1 24
8.2%
2.9%
EPS (diluted)
CBT
CBT
FOUR
FOUR
Q4 25
$1.37
Q3 25
$0.80
Q2 25
$1.86
Q1 25
$1.69
Q4 24
$1.67
Q3 24
$2.41
Q2 24
$1.94
Q1 24
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
FOUR
FOUR
Cash + ST InvestmentsLiquidity on hand
$230.0M
$964.0M
Total DebtLower is stronger
$4.5B
Stockholders' EquityBook value
$1.6B
$1.4B
Total Assets
$3.8B
$8.7B
Debt / EquityLower = less leverage
3.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
FOUR
FOUR
Q4 25
$230.0M
$964.0M
Q3 25
$258.0M
$1.5B
Q2 25
$239.0M
$3.0B
Q1 25
$213.0M
$1.2B
Q4 24
$183.0M
$1.2B
Q3 24
$223.0M
$1.4B
Q2 24
$197.0M
$205.0M
Q1 24
$206.0M
$522.9M
Total Debt
CBT
CBT
FOUR
FOUR
Q4 25
$4.5B
Q3 25
$1.1B
$4.7B
Q2 25
$3.7B
Q1 25
$2.8B
Q4 24
$2.8B
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
CBT
CBT
FOUR
FOUR
Q4 25
$1.6B
$1.4B
Q3 25
$1.6B
$1.7B
Q2 25
$1.5B
$1.6B
Q1 25
$1.4B
$805.2M
Q4 24
$1.4B
$806.6M
Q3 24
$1.4B
$811.8M
Q2 24
$1.3B
$700.8M
Q1 24
$1.4B
$674.5M
Total Assets
CBT
CBT
FOUR
FOUR
Q4 25
$3.8B
$8.7B
Q3 25
$3.8B
$9.0B
Q2 25
$3.8B
$7.0B
Q1 25
$3.8B
$5.0B
Q4 24
$3.6B
$5.0B
Q3 24
$3.7B
$5.0B
Q2 24
$3.6B
$3.5B
Q1 24
$3.6B
$3.4B
Debt / Equity
CBT
CBT
FOUR
FOUR
Q4 25
3.15×
Q3 25
0.70×
2.83×
Q2 25
2.34×
Q1 25
3.53×
Q4 24
3.52×
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
FOUR
FOUR
Operating Cash FlowLast quarter
$126.0M
$223.7M
Free Cash FlowOCF − Capex
$57.0M
$222.5M
FCF MarginFCF / Revenue
6.7%
18.7%
Capex IntensityCapex / Revenue
8.1%
0.1%
Cash ConversionOCF / Net Profit
1.73×
5.56×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$624.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
FOUR
FOUR
Q4 25
$126.0M
$223.7M
Q3 25
$219.0M
$171.8M
Q2 25
$249.0M
$141.9M
Q1 25
$73.0M
$96.6M
Q4 24
$124.0M
$145.4M
Q3 24
$204.0M
$182.1M
Q2 24
$207.0M
$116.1M
Q1 24
$176.0M
$56.7M
Free Cash Flow
CBT
CBT
FOUR
FOUR
Q4 25
$57.0M
$222.5M
Q3 25
$155.0M
$165.4M
Q2 25
$188.0M
$141.0M
Q1 25
$1.0M
$95.1M
Q4 24
$47.0M
$143.8M
Q3 24
$112.0M
$180.1M
Q2 24
$155.0M
$113.9M
Q1 24
$133.0M
$55.4M
FCF Margin
CBT
CBT
FOUR
FOUR
Q4 25
6.7%
18.7%
Q3 25
17.2%
14.1%
Q2 25
20.4%
14.6%
Q1 25
0.1%
11.2%
Q4 24
4.9%
16.2%
Q3 24
11.2%
19.8%
Q2 24
15.3%
13.8%
Q1 24
13.1%
7.8%
Capex Intensity
CBT
CBT
FOUR
FOUR
Q4 25
8.1%
0.1%
Q3 25
7.1%
0.5%
Q2 25
6.6%
0.1%
Q1 25
7.7%
0.2%
Q4 24
8.1%
0.2%
Q3 24
9.2%
0.2%
Q2 24
5.1%
0.3%
Q1 24
4.2%
0.2%
Cash Conversion
CBT
CBT
FOUR
FOUR
Q4 25
1.73×
5.56×
Q3 25
5.09×
6.11×
Q2 25
2.47×
4.17×
Q1 25
0.78×
5.78×
Q4 24
1.33×
1.25×
Q3 24
1.49×
3.38×
Q2 24
1.90×
2.96×
Q1 24
2.10×
2.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

FOUR
FOUR

Payments Based Revenue$788.8M66%
Other$255.0M21%
Subscription And Other Revenues$144.8M12%

Related Comparisons